BridgeWell Learn GLP-1 side effects and what to ask your clinician

GLP-1 side effects and what to ask your clinician

GLP-1 receptor agonists are highly effective for many people and have a side-effect profile most patients find manageable. They also carry real risks that should be discussed openly with the licensed clinician supervising your treatment. Here's a practical map of what to know.

BridgeWell does not prescribe medications and does not guarantee that any treatment will be prescribed. Eligibility for treatment is determined individually by a licensed clinician at our independent clinical partner. This page is for education and is not a substitute for professional medical advice.

Last updated 2026-05-07

Common side effects (and how they typically progress)

Nausea is the most frequently reported side effect, especially during the first few weeks of each dose increase. Vomiting, diarrhea, constipation, and decreased appetite are also common.

These usually peak during titration and improve as the body adjusts. Many patients find them manageable with smaller, more frequent meals; avoiding very high-fat or greasy foods early in titration; staying hydrated; and a slower titration pace under clinician supervision.

Heartburn, fatigue, and headaches are also reported. Some patients notice changes in taste or smell.

Less common but more serious risks

Pancreatitis (inflammation of the pancreas) is uncommon but can be serious. Severe abdominal pain — especially pain that radiates to the back, with or without vomiting — is a reason to contact your clinician promptly.

Gallbladder disease, including gallstones and cholecystitis, has been reported, particularly with rapid weight loss. Symptoms include severe right upper-abdominal pain, fever, or jaundice.

Diabetic retinopathy worsening has been observed in patients with pre-existing retinopathy and rapid blood-sugar improvement.

Allergic reactions are rare but possible. Rash, swelling, breathing difficulty, or anaphylaxis-like symptoms warrant emergency care.

Contraindications you should disclose during evaluation

A personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2 (MEN-2) is a contraindication for GLP-1 receptor agonists.

Pregnancy, breastfeeding, and active plans to conceive are typically reasons to avoid or pause treatment.

A history of pancreatitis, severe gastrointestinal disease (such as gastroparesis), severe gallbladder disease, or diabetic retinopathy may influence the clinician's decision or require additional monitoring.

Questions worth asking your clinician

What side effects should I expect in the first few weeks, and what's the plan if they're severe?

Which symptoms should make me call you immediately, versus which can wait until the next check-in?

How will we manage the dose if side effects are intolerable — pause, slow down, or switch?

What signs would tell us this medication isn't right for me, and what's the alternative?

Are there any drug interactions with my current medications I should know about?

When to call your clinician — not a chat bot

Severe abdominal pain, especially radiating to the back. Persistent vomiting that prevents hydration. Signs of an allergic reaction. Vision changes. Severe right-upper-abdominal pain with fever.

These are situations that warrant a real conversation with the licensed clinician supervising your treatment — not a forum, not a chat bot, not a social media post. Your clinical partner can usually respond same-day to urgent symptom messages.

Ready to find out where you stand?

Start an online eligibility check. A licensed clinician at our independent clinical partner reviews your information and decides whether medically supervised treatment is appropriate. No guarantees — just a real answer.

Check my fit

Frequently asked

Most patients find that nausea peaks during dose titration and improves as the body adjusts. Speak with your clinician if it doesn't improve or interferes with hydration — they can adjust the titration pace or switch the approach.
Smaller, more frequent meals; avoiding very high-fat or greasy foods early in titration; staying hydrated; and a slower titration pace under clinician supervision all help. Discuss specific strategies with your clinician — there's no one-size-fits-all answer.
It is uncommon but well-documented. The risk is one of the reasons clinicians screen carefully and follow up actively. Severe abdominal pain — especially pain that radiates to the back — warrants prompt clinician contact.
Talk to your clinician before stopping or changing your dose. They can advise on whether to pause, slow titration, switch medications, or continue. Self-discontinuation can have its own risks depending on the situation.
Mood changes have been reported, though the data is mixed. If you notice persistent mood changes, anxiety, or thoughts of self-harm, talk to your clinician — these warrant a real conversation regardless of the cause.

Ready to see if you qualify?

Start your online eligibility check. A licensed clinician at our independent clinical partner reviews your information and decides whether medically supervised treatment is clinically appropriate.

BridgeWell does not prescribe medications and does not guarantee that any treatment will be prescribed. Not a substitute for professional medical advice.